Results 81 to 90 of about 397,654 (324)

06-11-1986 Justice Powell, Per Curiam [PDF]

open access: yes, 1986
In 1978, petitioner Earl Allen, a black man, was indicted for murdering his girlfriend and her brother. During selection of the petit jurors at petitioner\u27s trial. the prosecutor exercised 9 of the State\u27s 17 peremptory challenges to strike 7 black
Powell, Lewis F
core   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

The Tormentor from Toruń’s Fort VII, Karl Friedrich Strauss, on the Defendant Bench

open access: yesHistoria i Polityka, 2019
The paper focuses on the trial of Karl Friedrich Strauss, who from the end of October 1939 until January 1940 served as the administrative commandant of Fort VII in Toruń, which hosted an internment camp for civilians (Zivilinternierungslager).
Sylwia Grochowina
doaj   +1 more source

Should Trial by Jury Be Eliminated in Complex Cases [PDF]

open access: yes, 1990
One way in which the public participates in the management of Risk is as jurors. Here, the function of juries in civil litigation is discussed and the argument is made that problems with juries in complex cases may be solved by means short of eliminating
Bownes, Hugh H.
core   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Aproximación al estudio de la justicia penal negociada de los EE.UU : The Plea Bargaining Process [PDF]

open access: yes, 1995
The purpose of this article is to explain the guilty plea system in the criminal courts, because the right to a trial by jury, a right guaranteed by the sixth amendment, has\ud been seriously undermined by the huge criminal case load and the limited ...
Rodríguez García, Nicolás
core   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

The Case, Trevett against Weeden [PDF]

open access: yes
Wherein the Rights of the People to Trial by Jury, &c. are dated and maintained, and the Legislative, Judiciary and Executive Powers of Government examined and ...

core   +1 more source

The English Jury on Trial [PDF]

open access: yes, 2017
Within the English criminal justice system, trial by jury remains the gold standard means of delivering justice. The complex mix of evidence against those accused, alongside testimony, which challenges the police interpretation of the facts, is thought ...
Boduszek, Daniel   +2 more
core  

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy